Market Insights Health Hospitals Inpatient Care

Midwifery - Suriname

Suriname

in Suriname, a country South_America, is also expected to see growth in the Midwifery market.
By 2024, the projected revenue in this market is estimated to reach US$3.65m.
This indicates a positive trend, with an annual growth rate of 7.70% predicted for the period between 2024 and 2029.
By the end of 2029, the market volume is expected to reach US$5.29m.
When comparing in Suriname to the global market, it is important to note that United States is projected to generate the highest revenue in the Midwifery market, with an estimated value of US$34,040.00m in 2024.
This highlights the significant contribution of the United States to the global market.
In Suriname, the midwifery market is experiencing a surge in demand due to the country's cultural preference for home births.

Key regions: France, Europe, Japan, Germany, United Kingdom

Market

Region

Region comparison

Currency

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on revenue received by hospitals from public or private sources, allocated to the country where the money is spent, including VAT if applicable.

Modeling approach / Market size:

Market sizes are determined by a bottom-up approach, based on a specific rationale for each market market. Next, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, public health spend, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.